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Membrane-Bound TNF Supports Secondary Lymphoid
Organ Structure but Is Subservient to Secreted
TNF in Driving Autoimmune Inflammation
is superior to solTNF in activating TNF-R2 (Grell et al.,
1995). TNF-R1 contains a death domain mediating apo-
ptosis upon ligand binding, whereas TNF-R2 does not.
However, evidence exists that signals through TNF-R2
can initiate cell death by enhancement of TNF-R1 signal-
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ing (Grell et al., 1999). Alternatively, TNF-R2 engagement1DNAX
leads to binding of TNF-R-associated factors 1 and 2,901 California Avenue
leading to NF-B activation and cell survival (Yeh et al.,Palo Alto, California 94304
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TNF is ascribed a wide range of activities, particularlyUniversity of California, San Francisco
those associated with resistance to intracellular bacte-San Francisco, California 94143
rial infections, proinflammatory properties, and induc-3 Interdisziplinares Zentrum fu¨r Klinische Forschung
tion of apoptosis. A critical function of TNF is its abilityder Universita¨t Erlangen-Nu¨rnberg
to regulate leukocyte movement through actions on che-Erlangen
mokine expression. This in turn controls the microarchi-Germany
tecture of lymphoid tissues as well as the tempo and
nature of inflammatory reactions in autoimmunity and
infection (Pfeffer et al., 1993; Sedgwick et al., 2000).Summary
Additional contributions of TNF to development of auto-
immune inflammation relate to its capacity to stimulateMice without secreted TNF but with functional, nor-
antigen presentation and dendritic cell maturation andmally regulated and expressed membrane-bound TNF
movement (Green and Flavell, 1999). Other data indicate(memTNF/ mice) were created by knocking-in the
that under certain circumstances TNF plays an oppositeuncleavable 1-9,K11E TNF allele. In contrast to TNF-
role to that most commonly ascribed to it, preventingdeficient mice (TNF/), memTNF supported many fea-
rather than promoting immune responses (Cope, 1998).tures of lymphoid organ structure, except generation
This effect manifests particularly in chronic immune re-of primary B cell follicles. Splenic chemokine expres-
sponses and could be missed in shorter-term analysession was near normal. MemTNF-induced apoptosis
(Kassiotis and Kollias, 2001).was mediated through both TNF-R1 and TNF-R2. That
The relative roles of memTNF versus solTNF in thismemTNF is suboptimal for development of inflamma-
plethora of functions in vivo have not been determined,tion was revealed in experimental autoimmune en-
in large part due to the absence of physiologically rele-cephalomyelitis. Disease severity was reduced in
vant models that enable the two forms of TNF to bememTNF/ mice relative to wild-type mice, and the
compared. To date, the main evidence for an in vivonature of spinal cord infiltrates resembled that in
role for memTNF has come from transgenic mice, inTNF/ mice. We conclude that memTNF supports
which uncleavable TNF was overexpressed in variousmany processes underlying lymphoid tissue structure,
organs (Akassoglou et al., 1997). These studies havebut secreted TNF is needed for optimal inflammatory
been valuable in demonstrating that memTNF can inlesion development.
principal play a role in tissue destruction and autoim-
mune inflammation. However, such approaches are im-Introduction
perfect as (mem)TNF expression is tightly regulated,
and artificially high levels of this molecule might enable
Tumor necrosis factor (TNF) is a cytokine produced pre-
immunological or pathological processes to be initiated
dominantly by activated macrophages but is also ex- that would not occur normally. A recent study addressed
pressed by lymphocytes, natural killer cells, mast cells, this by generating memTNF transgenic mice in which
endothelial cells, fibroblasts, and microglial cells (Vas- expression was controlled by the TNF promotor and the
salli, 1992). Its central role in inflammatory and autoim- 3 AU-rich elements of the TNF genomic locus to assure
mune diseases is now validated in the clinic through the adequate gene regulation in vivo (Mueller et al., 1999).
use of TNF-neutralizing therapeutics (Feldmann et al., However, these mice were generated on a TNF/LTdou-
1998). TNF is first produced as a 26 kDa transmembrane ble-deficient background. Such mice have defective
molecule (memTNF) which is cleaved by the metallopro- lymphoid tissue neogenesis (Fu and Chaplin, 1999),
teinase-disintegrin TACE (TNF  converting enzyme; which makes interpretation of the outcome of immune
Black et al., 1997; Moss et al., 1997) to generate a soluble responses challenging.
17 kDa molecule (solTNF). Studies in vitro have shown Finally, previous approaches to create animals or cells
that memTNF is biologically functional (Decker et al., that express only memTNF have varied greatly and are
1987; Kriegler et al., 1988). Membrane as well as solTNF not comparable to one another. One approach, to pre-
interact with two TNF receptors, TNF-R1 and TNF-R2 vent TNF secretion with TACE inhibitors (Gearing et al.,
(Bazzoni and Beutler, 1996). Generally, solTNF is re- 1994; McGeehan et al., 1994; Mohler et al., 1994) or by
garded as the main ligand for TNF-R1, whereas memTNF gene targeting of TACE (Peschon et al., 1998), is now
recognized not to enable memTNF expression alone,
given that TACE is responsible for cleavage of cell-mem-4 Correspondence: jon.sedgwick@dnax.org
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brane proteins other than TNF, including TGF, L-selec- tion of TNF molecules from both a cleavable and an
uncleavable TNF allele in memTNF/ mice indicates thetin, and TNF-R2 (Peschon et al., 1998). The more precise
approach, creating uncleavable TNF for transgenesis, theoretical level of TNF secretion in heterozygous mice
to be approximately 25% of that of WT. Our findingsin vitro transfection, or gene knock-in in vivo, creates
yet another variable whereby the actual mutation used therefore suggest that, at least in memTNF/ mice, TNF
secretion is further regulated.to render the TNF allele uncleavable may vary. In most
studies, the1-12 TNF mutation has been used, in which To test whether the introduced mutation in the TNF
gene interfered with expression levels of TNF at the cellthe entire TNF cleavage site was deleted. Although
memTNF produced through this mutation has biological surface, FACS analysis of LPS-stimulated PECs was
performed. In three separate studies, one of which isfunction, its in vitro bioactivity is much reduced com-
pared to wild-type (WT) memTNF or that produced by illustrated here (Figure 2B), LPS-stimulated F4/80PECs
from WT, memTNF/, and memTNF/ mice exhibitedother more minimal deletion/point mutation approaches
(Decoster et al., 1995). remarkably similar levels of TNF expression at the
cell surface, although with evidence of marginallyWe describe here the creation and analysis of mice
that express only the memTNF form, replacing the en- higher memTNF expression in WT versus memTNF/
or memTNF/ PECs. As expected, PECs from TNF/dogenous TNF allele by knocking-in the 1-9,K11E TNF
allele (memTNF/ mice). This deletion/mutation combi- mice did not express TNF at the cell surface.
Previously, it has been reported that alterations intro-nation was chosen to ensure complete loss of TACE-
mediated cleavage but normal cell-surface expression duced by gene targeting in one gene can influence ex-
pression of closely located genes, especially when theand function of memTNF (Decoster et al., 1995). Further,
as the TNF gene is located within the MHC locus, and selectable marker is not removed (Olson et al., 1996;
Pham et al., 1996). Here, where normal gene expressionmany genes that are involved in genetic susceptibility
to various diseases are linked within this locus (Ruuls is critical, the neomycin resistance cassette was re-
moved from the genome. We measured TNF mRNA ex-and Sedgwick, 1999), we generated the memTNF/
mice directly on the C57BL/6 genetic background, used pression levels in LPS-stimulated PECs by quantitative
real-time PCR. Expression levels in WT spleen were setin a wide variety of disease models.
These studies define the contributions that memTNF to 100%, and expression levels in gene-targeted mice
were expressed as a percentage of WT. As in all PCR-alone makes to the basic phenotype of lymphoid organ
structure, the capacity of memTNF to induce chemokine based strategies, the amount of product formed doubles
in each cycle. However, the detection system used isexpression in spleen, and the TNF receptors through
which normally expressed memTNF effects cellular apo- not sensitive enough to distinguish differences smaller
than one cycle threshold (CT). Thus, any difference inptosis. Furthermore, despite published evidence impli-
cating memTNF as a potent inducer of inflammatory mRNA expression of less than 2-fold was not considered
to be significant. As shown in Figure 2C, TNF gene ex-processes in vivo, we show here that normally regulated
memTNF exhibits suboptimal proinflammatory func- pression was completely abolished in TNF/ PECs but
was normal in memTNF/ and memTNF/ PECs. Thus,tions in vivo.
even at the transcriptional level, memTNF/ mice were
comparable to WT mice. Genetic inactivation or alter-Results
ation of TNF could in principle influence expression of
genes normally regulated by TNF. Given the importanceGeneration and Functional Characterization
of LT and LT for lymphoid organ development andof MemTNF/ Mice
structural organization (Fu and Chaplin, 1999), the factThe C57BL/6 ES cell line Bruce 4 was transfected with
that these genes flank TNF, and that little is known aboutthe memTNF targeting construct (Figure 1A), and the
the regulation of LT expression by TNF, we measuredneomycin resistance cassette was excised (Figure 1B).
mRNA expression levels of TNF, LT, and LT in unmani-ES cell subclones were injected into BALB/c blasto-
pulated spleens. TNF expression levels in spleen con-cysts to generate chimeras and founder memTNF/
firmed the observation in PECs (Firgure 2D). Expressionmice (Figure 1C). Offspring of intercrossed memTNF/
of both LT and LT genes was comparable in WT,mice showed normal Mendelian inheritance ratios.
memTNF/, and memTNF/ spleen, and slightly butmemTNF/ and memTNF/ mice were grossly normal
not significantly reduced in TNF/ spleen. Our TNF/in appearance, bred normally, and had life spans com-
mice retained the neomycin resistance cassette (Ko¨rnerparable to WT mice.
et al., 1997a), but apparently without significant effectTo verify successful mutation of TNF and lack of se-
on flanking genes.cretion of TNF by memTNF/ cells, peritoneal exudate
cells (PECs) were stimulated with LPS in vitro, and
solTNF levels in supernatants were determined. Both in LPS-Stimulated PECs from MemTNF/ Mice Kill
WEHI-164 Cells in a TNF-R1- and TNF-R2-ELISA (data not shown) and bio-assay (Figure 2A), high
amounts of solTNF were detected in supernatant of LPS- Dependent Manner
To assess functionality of cell-surface expressed TNF instimulated WT PECs, but no detectable levels of solTNF
were measured in supernatant of either TNF/ or memTNF/ mice, PECs were formalin fixed (to prevent
secretion of TNF from WT and memTNF/ cells) andmemTNF/ cells (detection limit of ELISA  75 pg/ml;
bio-assay  0.8 pg/ml). Unexpectedly, PECs from tested for their capacity to kill TNF-sensitive target cells.
As shown in Figure 2E, PECs from WT, memTNF/,memTNF/ mice secreted only around 10% of WT TNF
levels. Consideration of the stoichiometry of trimeriza- as well as memTNF/ mice efficiently lysed WEHI-164
Membrane-Bound TNF Activities In Vivo
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Figure 1. Creation of MemTNF/ Mice
(A) Targeting construct for replacement of
endogenous TNF gene with uncleavable
1-9,K11E TNF. See Experimental Proce-
dures for cloning strategy and a detailed de-
scription of Southern and PCR screening
strategies. I–IV indicate exon numbers. Re-
striction enzyme sites: M, MscI; S, SmaI. Tri-
angles indicate loxP sites. Bases indicated in
capitals were deleted/exchanged using PCR-
based site-directed mutagenesis.
(B) Predicted structure of the targeted TNF
locus before and after Cre transfection.
Hatched exons II and III of TNF indicate that
changes were made to these exons to render
TNF uncleavable. Probe I indicates a 650 bp
EcoRI fragment used for screening for homol-
ogous recombination in ES cells. Probe II indi-
cates a PCR-generated probe of TNF exon I
used to screen for successful removal of the
neomycin resistance cassette after Cre trans-
fection. Restriction enzyme sites: P, PstI; E,
EcoRI. Arrows indicate primers used in PCR
screening of chimera and heterozygous
mouse intercross offspring.
(C) PCR screening of offspring of heterozy-
gous mouse intercross.
cells. At an E:T ratio of 1:1, no differences were observed ratio, cell lysis was again observed in all cases, although
variability was now apparent with some evidence thatin lytic efficiency. As expected, fixed PECs from TNF/
mice did not kill WEHI-164 cells. At a 10-fold lower E:T cells from memTNF/ and memTNF/ mice were less
Figure 2. MemTNF/ Mice Fail to Secrete
TNF but Express Functionally Normal TNF at
the Cell Surface
(A) LPS-stimulated memTNF/ PECs do not
secrete TNF. TNF levels were measured in
supernatants from 3 hr LPS-stimulated cul-
tures. Data are mean	 SEM of five individual
mice. Asterisks denote difference with WT
TNF levels is statistically significant, p 0.05,
Student’s t test.
(B) Flow cytometric analysis of LPS-stimu-
lated plastic-adherent PECs. Histograms
shown are gated on F4/80 cells. Dotted lines
denote PE-conjugated isotype control; solid
lines denote PE-conjugated anti-mouse TNF
(XT22).
(C and D) TNF mRNA expression levels in
LPS-stimulated PECs ([C]) and normal spleen
([D]). All mRNA levels were normalized for
rRNA content in the sample. Data shown are
relative to levels in WT mice (set at 100%)
and are mean 	 SEM, each group consisting
of four ([C]) or five ([D]) individual mice.
(E) In vitro killing of WEHI 164 cells by LPS-
stimulated, paraformaldehyde-fixed macro-
phages. Data from a representative experi-
ment using an effector (macrophage) to target
(WEHI 164) ratio of 1:1 and 1:10 are shown.
Pooled peritoneal cells from two thioglyco-
late-injected animals per genotype were
used. Macrophage-mediated killing is ex-
pressed as equivalent of killing induced by
soluble, recombinant TNF (pg/ml). Antibodies
were all used at a concentration of 10 
g/ml.
Data in (B) and (E) were repeated three times
with comparable outcomes.
Immunity
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and low doses of LPS (Figure 3B). TNF/ mice were
resistant as expected. MemTNF/ mice showed no evi-
dence of LPS shock when injected with 1 
g LPS. With
100-fold more LPS, most memTNF/ mice started to
show signs of shock (ruffled fur, fever, and lethargy)
7 hr after injection. However, only two out of five mice
succumbed to shock, and time of death was delayed
markedly compared to WT or memTNF/ mice.
Improved Lymphoid Organ Structure and Partially
Restored Germinal Center Formation
in MemTNF/ Mice
In WT spleen, T and B cell areas were clearly segregated,
and B cells were organized in primary follicles (Figures
4A and 4E). A similar, highly organized structure was
seen in spleen of memTNF/ mice (Figures 4B and 4F).
This organization was lost in TNF/ spleen, in which
primary B cell follicles were absent, with B cells forming
a ring-like structure around the T cell area (Figure 4D;
Pasparakis et al., 1996; Ko¨rner et al., 1997a). At higher
magnification, loss of B and T cell area segregation
becomes apparent in TNF/ spleen (Figure 4H). memTNF
did not enable primary B cell follicle formation (Figure 4C).
Close analysis of the degree of T/B cell region segregation
indicated improvement relative to TNF/ mice (Figure
4G versus 4H), although not to the level seen in WT or
memTNF/ spleen (Figures 4E and 4F).
The splenic white pulp is surrounded by a marginal
zone, in which lymphocytes enter the white pulp area
through the marginal sinus. In WT and memTNF/ mice,
Figure 3. LPS-Induced Serum TNF and Dose-Dependent Protection
MOMA-1 marginal zone metallophilic macrophagesfrom Endotoxic Shock
(MM) form a distinct continuous cell layer (Figure 4I).(A) Serum TNF levels of mice 2 hr after i.p. injection of 100 
g LPS/
These MOMA-1 MM are virtually absent in TNF/20 mg D-galactosamine (mean	SEM, n 9 mice). Asterisks denote
spleen (Figure 4L; Pasparakis et al., 2000). MemTNFdifference with WT TNF levels is statistically significant, p  0.003,
Student’s t test. supported a marked increase in the number of MOMA-
(B) Clinical outcome of LPS-induced shock after i.p. injection of 1 1 MM (Figure 4K), although these cells did not form a
or 100 
g LPS/20 mg D-galactosamine. Lines indicate proportion completely continuous cell layer.
of mice (n  5) that survive LPS-induced shock from 3 to 55 hr after
Within the marginal sinus, lining cells express the ad-LPS injection.
dressin MadCAM-1 (Figure 4M). This expression is al-
most completely lost in TNF/ spleen (Figure 4P; Ko¨rner
et al., 1997a). In the presence of memTNF, MadCAM-1efficient, possibly reflecting the marginally reduced
memTNF expression in these mouse strains (Figure 2B). expression is substantially restored (Figure 4O).
Formation of follicular dendritic cell networks and ger-Killing was completely blocked by neutralizing anti-
mouse TNF mAb, XT22. To examine which receptor is minal centers (GCs) upon immunization requires TNF
(compare Figures 4Q and 4U with Figures 4T and 4X;involved, neutralizing anti-mouse TNF-R1 and TNF-R2
antibodies were added. Blockade of both TNF-R1 or Pasparakis et al., 1996; Cook et al., 1998). MemTNF
supported formation of PNA GCs (Figure 4S) and ap-TNF-R2 substantially reduced cell lysis, although TNF-
R1 blockade was most effective. propriately positioned CR1 FDC networks (Figure 4W),
but at a size and frequency substantially less than in
WT or memTNF/ mice. In unimmunized mice, CR1Resistance to LPS-Induced Shock
in the Absence of SolTNF FDC networks were detectable in WT but not in
memTNF/ mice (data not shown). Formation of GC andTo investigate the relative contribution of soluble and
membrane-bound TNF to the clinical outcome of LPS- FDC networks was completely normal in memTNF/
spleen (Figures 4R and 4V). Lymphoid tissues other thaninduced shock, mice were injected with two different
doses of LPS (100 or 1 
g/mouse) in combination with spleen are affected by the absence of TNF, especially
the Peyer’s patch (PP), which exhibit a flattened appear-D-galactosamine. Blood was drawn from mice 3 hr after
receiving 100 
g LPS and tested for serum TNF (Figure ance and in which T and B cells intermix freely (Figure
5C; Ko¨rner et al., 1997a). MemTNF restored PP structure3A). Consistent with in vitro studies (Figure 2A), no solu-
ble TNF was detected in serum of TNF/ or memTNF/ to a substantial degree with separation of T and B cell
regions, although again with imperfect primary B cellmice, and again much less TNF was secreted in
memTNF/ mice (mean 422 pg/ml) versus WT mice follicles (Figure 5B versus 5A). Effects of memTNF on
lymph node structure (Figure 5E) were comparable to(mean 3776 pg/ml). WT and memTNF/ mice were fully
susceptible to endotoxic shock induced by both high that in spleen, with loss of primary B cell follicles, seen
Membrane-Bound TNF Activities In Vivo
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Figure 4. MemTNF Is Sufficient for MOMA-1 and MadCAM-1 Expression and Germinal Center Formation but Not for Primary B Cell Follicle
Structure
Spleen sections from 8- to 10-week-old mice were used for immunohistochemical analysis. (A)–(D) show lack of primary B cell follicle formation
in TNF/ and memTNF/ spleen. B, B lymphocytes (B220, brown); T, T lymphocytes (CD4 plus CD8, blue). (E)–(H) show loss of T/B cell
segregation in spleen of TNF/ and memTNF/ mice. B, B lymphocytes (B220, red); T, T lymphocytes (CD3, green). Arrowheads indicate
T/B cell interface. (I)–(L) show preservation of MOMA-1 marginal zone metallophilic macrophages in memTNF/ but not in TNF/ spleen.
B, B lymphocytes (B220, brown); MM, marginal zone metallophilic macrophages (MOMA-1, blue). (M)–(P) show preserved MadCAM-1 expression
in marginal zone of memTNF/ but not TNF/ spleen. Sections were stained with anti-mouse MadCAM-1 antibody (blue). (Q)–(X) show that
memTNF supports partial germinal center formation and GC-associated FDC networks. Serial spleen sections (Q/U, R/V, etc.) from SRBC-
immunized mice were stained for B220 (brown) and PNA (blue) ([Q]–[T]) or CD35/CR1 (brown) ([U]–[X]). Arrowheads show PNA GCs ([Q]–[T])
and GC-associated CR1 FDC networks ([U]–[X]). Note that the small GC in memTNF/ spleen is positioned within the B cell area, not at the
T/B cell interface. The scale bar denotes 128 
m ([A]–[D]), 512 
m ([E]–[H]), 100 
m ([I]–[L], [Q]–[X]) or 80 
m ([M]–[P]).
in memTNF/ mice (Figure 5D) and WT mice (data not membrane TNF to this is not known. Thus, chemokine
gene expression levels were determined by real-timeshown) but not in TNF/ mice (Figure 5F).
quantitative PCR in normal spleens. Of 15 chemokines
known to be expressed in spleen (Figure 6A), expressionMemTNF Plays a Dominant Role in Steady-State
of only one was significantly lower in both TNF/ andChemokine Gene Expression
memTNF/ spleen. This chemokine, MCP-1, was ex-The microarchitecture of lymphoid tissue is maintained
pressed at low levels in WT spleen, with the detectionby chemokines, and normal expression of these is de-
threshhold reached at cycle 31, compared to, for in-pendent on LT and TNF (Cyster et al., 2000; Sedgwick
et al., 2000). The relative contribution of soluble versus stance, BLC at cycle 24. It was found to be 4.5 times
Immunity
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Figure 5. MemTNF Supports Follicular Orga-
nization in Peyer’s Patches but Not Lymph
Nodes
Sections were stained for B lymphocytes
(B220, brown) and T lymphocytes (CD4 plus
CD8, blue). Per Figure 4, WT mice were indis-
tiguishable from memTNF/ and are not
shown. The scale bar denotes 160 
m ([A]–
[C]) or 100 
m ([D]–[F]).
less in TNF/ spleen, and more than 2 times lower spleen, although not significantly so according to our
stringent criteria. Two chemokines, RANTES and TCA3,in memTNF/ spleen (Figures 6A and 6B). Two other
chemokines, BLC and MCP-3, were significantly lower expressed normally in TNF/ spleen, were significantly
increased in gene expression levels in mice expressingthan WT in TNF/ but not in memTNF/ spleen (Figures
6A and 6B). There was an overall theme of loss of chemo- only memTNF. A partial effect toward increased expres-
sion was also seen in memTNF/ mice (Figure 6B). Ex-kine gene expression in TNF/ mice which was rescued
to near WT levels by memTNF (Figures 6A and 6B). SLC pression of the receptors for BLC (CXCR5), SLC, and
MIP3 (CCR7) was not affected by the absence of allexpression, previously shown to be decreased in TNF/
spleens (Ngo et al., 1999), was downregulated in TNF/ TNF or the loss of solTNF. Expression of the MCP-1
Figure 6. MemTNF Dominates Chemokine Induction in Normal Spleen
(A) Chemokine expression. mRNA levels in normal spleen (n  5) were determined by Taqman real-time quantitative PCR. Cycle threshold
(CT) values of individual genes in WT spleen are given in parentheses in the first column. CT values are determined as the cycle number in
which the PCR product reaches a preset threshold level. A low CT value indicates high expression, and a high CT value indicates a low
expression level. Expression levels for TNF/ and memTNF/ mice are expressed as mean percent expression relative to WT spleen. Figures
in bold are those that are more than 2-fold lower or higher than WT and considered to be different to WT.
(B) mRNA expression levels of those genes shown to be differentially expressed from WT for all genotypes. Data are expressed as percentage
of mRNA expression relative to those in WT spleen (mean 	 SEM, n  5). Dotted lines indicate 2-fold increase or decrease in expression
relative to WT.
(C–F) In situ hybridization (ISH) analysis of BLC in sections of normal spleen. Blue, ISH signal; brown, immunohistochemical staining for B220
(B lymphocytes). The scale bar denotes 50 
m.
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Figure 7. SolTNF Is Required for Full Development of EAE under Suboptimal Immunization Conditions
Clinical disease and incidence of EAE in mice immunized with MOG peptide in CFA containing 1 mg M. tuberculosis/mouse ([A]) or 0.1 mg
M. tuberculosis/mouse ([C]). Clinical scores are presented as mean score of all mice in the experimental groups (n  10 [A] or n  9 [C]).
Cumulative incidence is presented as proportion of mice that showed clinical signs of EAE until a given day. Each experiment was repeated
once with similar outcome. (B) shows spinal cord inflammatory infiltrates. Mice were immunized with MOG-peptide in CFA (1 mg M. tuberculosis/
mouse). Spinal cords were isolated when mice first reached peak of disease (day 18 after immunization for WT, memTNF/, and memTNF/
mice; day 24 for TNF/ mice). Sections were stained for CD45. The scale bar denotes 50 
m.
receptor CCR2 was slightly reduced in memTNF/ ever, disease progressed with similar severity and inci-
dence as in WT. Disease progression both in memTNF/spleen (data not shown).
and memTNF/ mice was indistinguishable from that inIncreased gene expression of BLC in memTNF/ ver-
WT (Figure 7A), suggesting that, at least in inflammation,sus TNF/ spleen was confirmed at the morphological
memTNF is sufficient to mediate all TNF-dependent pro-level using nonradioactive in situ hybridization. Although
cesses. That this is in fact not the case was revealedthis technique is not quantitative, compared to WT a
first by analysis of spinal cord inflammatory infiltratesclear reduction in BLC expression in the B cell area of
(Figure 7B), where loss of solTNF (memTNF/ mice)TNF/ spleen was seen (compare Figure 6C versus 6D),
resulted in the same congested CD45 perivascularwith increased expression in memTNF/ spleen (Figure
cuffs described previously in TNF/ mice. To assess6E) and memTNF/ spleen (Figure 6F) relative to TNF/
whether clinical effects of loss of solTNF could be re-spleen.
vealed, mice were immunized with MOG 35-55 peptide
but with a 10-fold lower dose (0.1 mg) of M. tuberculosis
Clinical and Histological Evaluation of EAE in CFA to reduce the strength of the inflammatory stimu-
in TNF/ and MemTNF/ Mice lus (Figure 7C). This did not influence clinical outcome in
Immunization of WT mice with MOG 35-55 peptide in WT or memTNF/ mice substantially. However, clinical
CFA (1 mg M. tuberculosis/mouse) accompanied by in- outcome in both TNF/ and memTNF/ mice changed
travenous injection of pertussis toxin resulted in devel- dramatically. In TNF/ mice, the incidence of disease
opment of ascending paralysis on or around day 10, dropped to below 40%, and clinical signs were very
reaching peak of severity within 5–6 days (Figure 7A). mild, resolving quickly (Figure 7C). While the disease
In TNF/ mice, a similar immunization regime produced incidence in memTNF/ mice was comparable to that
a delay in onset of clinical signs, as reported previously at high CFA levels, severity of disease was reduced,
with the majority of mice recovering rapidly (Figure 7C).(Figure 7A; Ko¨rner et al., 1997b). Once established, how-
Immunity
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Discussion membrane TNF have distinct roles in lymphoid organ
structure. MemTNF is sufficient for proper localization
and development of components of the marginal zone,It was recognized more than a decade ago that memTNF
including MOMA-1 macrophages and MadCAM-1-can exert a biological function in vitro (Kriegler et al.,
expressing marginal sinus. SolTNF nevertheless ap-1988). Here we show that soluble and membrane TNF
pears to be necessary for the formation of primary Bhave distinct functions in structural organization of
cell follicles and primary FDC networks. In contrast tolymphoid organs, chemokine expression, and autoim-
reports showing that transgenic overexpression ofmune inflammation. Most importantly, these data do not
TNF1-12 in TNF/ mice can completely restore FDCsupport the generally accepted notion that memTNF is
networks and GC formation (Pasparakis et al., 1996),fully equivalent to solTNF in driving inflammatory pro-
immunization of memTNF/ mice induced FDC net-cesses.
works and GCs whose size and number were inferior toCritical to interpretation of the role of memTNF in vivo
that in WT mice. FDC/GC in memTNF/ mice resembledwas development of a gene-targeted/mutation model
that of mice deficient in BLC or its receptor CXCR5that enabled faithful expression and activity of memTNF
(Ansel et al., 2000; Voigt et al., 2000), but in contrastcomparable to that in WT mice. We achieved that here.
to GCs formed in the absence of BLC/CXCR5, GCs inImportantly, there was no indication of a general dysreg-
memTNF/ mice were properly positioned within the Bulation of TNF surface expression, nor accumulation of
cell area.TNF at the cell surface. This indicates that, at least in
Appropriate chemokine expression is necessary formacrophages, surface expression of TNF is tightly regu-
correct lymphoid organ structure (Cyster et al., 2000),lated, and a feedback mechanism exists to control the
and inability of leukocytes to localize normally in tissuesamount of memTNF independent of TACE-mediated
of TNF/ mice is a consequence of disrupted regulationcleavage. Moreover, our data on TNF mRNA expression
of chemokine expression (Sedgwick et al., 2000). Tolevels in memTNF/ PECs suggest that this regulation
extend these studies, real-time quantitative PCR wasis at the posttranscriptional level. Our findings are not
used to screen a large panel of chemokines. These dataconsistent with previous reports showing increased ex-
confirmed the TNF-dependent nature of BLC expressionpression of memTNF at the cell surface and enhanced
in spleen but also showed two other chemokines,in vitro cell-mediated killing when secretion of TNF was
MCP-1 and MCP-3, to be dependent on TNF for mainte-prevented by treatment of cells with metalloprotease
nance of their expression. MCP-1 was the only chemo-inhibitors (Solomon et al., 1997). Notably, these inhibi-
kine significantly downregulated in both TNF/ andtors are not specific to TNF, also blocking secretion of
memTNF/ spleen, indicating that there is a role forother surface molecules, including TNF-R1, which may
both soluble and membrane TNF in regulation of itsimpact upon levels of detectable surface-bound TNF as
expression. MCP-1 gene expression is regulated by TNFwell as lytic function of treated cells.
in vitro (Gordon et al., 1992), but differential expressionMemTNF-mediated killing could be blocked com-
of MCP-1 in TNF/ versus WT mice has not been re-pletely by anti-TNF-R1 antibody and partially by anti-
ported before. Overall, memTNF supports chemokineTNF-R2 antibody. Earlier studies (Grell et al., 1995) had
implicated TNF-R2 as the receptor through which expression broadly but is insufficient to provide all
needed signals to fully maintain splenic (or PP/LN) mi-memTNF but not solTNF could mediate cell killing. TNF-
R1, by contrast, was shown to respond to both TNF croarchitectural structure. BLC expression is almost
normalized by memTNF, but this does not lead to forma-forms and signal apoptosis. Our studies indicate that
normally regulated memTNF can indeed deliver an apo- tion of primary B cell follicles, indicating that BLC is
necessary but not sufficient for this process.ptotic signal through both receptors, although the domi-
nant signal nevertheless is via TNF-R1. Even though the Expression of two chemokines, RANTES and TCA3,
doubled in memTNF/ mice. It remains unclear whatcytoplasmic region of TNF-R2 does not contain a “death
domain,” it has been proposed that it can potentiate the the in vivo implication of this is, but it indicates that
solTNF may play a downregulatory role in the expressionapoptotic response of TNF through TNF-R1, through
“ligand passing” or at the level of intracellular signaling of some chemokines. Notably, RANTES expression also
increased in memTNF/ mice expressing 10% of WT(Weiss et al., 1997). As ligand passing is unlikely to be
operative for memTNF/receptor interactions, our data levels of soluble TNF.
The exact role of TNF in CNS inflammation remainssupport the view that signaling of memTNF through TNF-
R2 can result in apoptosis by amplifying internal apo- controversial (Baker et al., 1994; Ko¨rner et al., 1997b;
Liu et al., 1998; Kassiotis and Kollias, 2001). What isptotic signal transduction through TNF-R1.
Several studies have indicated an important role for clear, however, is that TNF plays a dominant role in
disease onset and leukocyte infiltration into the CNS insolTNF in LPS shock models, as prevention of TNF
cleavage by metalloprotease inhibitors efficiently pre- the first phase of the disease (Riminton and Sedgwick,
2000; Kassiotis and Kollias, 2001). Our data show thatvents shock-related mortality (Gearing et al., 1994). Al-
though a high dose of LPS induced some effects in normally regulated memTNF is clearly insufficient for
inflammatory processes to proceed normally in thememTNF/ mice, death was delayed. Our data thus
confirm the dominant role for solTNF in LPS shock. brain. Studies using a standard dose of CFA (1 mg M.
tuberculosis/mouse) in the immunization inoculum, sug-An unexpected role for LT and TNF in lymphoid tissue
organogenesis and maintenance of microarchitecture gested that memTNF was fully capable of inducing clini-
cal signs of EAE, with memTNF/ mice developing dis-within these organs was revealed through gene tar-
geting (Pasparakis et al., 1996; Ko¨rner et al., 1997a; Fu ease at the exact same time as WT mice. In this
immunization regime, only TNF/ mice exhibited theand Chaplin, 1999). Our data show that soluble and
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MT2 were added. The reaction was continued for 15 cycles at 94Ctypical delay in onset of disease, as reported before
for 30 s, 66C for 30 s, and 72C for 1 min. Purified PCR product(Ko¨rner et al., 1997b; Kassiotis et al., 1999). Notably,
was subcloned in the EcoRI and XbaI sites of pBluescript. Thehowever, cell movement within the CNS was dramati-
process was repeated using the deletion mutant as template and
cally impaired in memTNF/ mice, resembling that of mutation primers MT5 (5-GACCCTCACAGTAAGTGTTCCCACAC
TNF/ mice. This has two implications. First, that a CTCTC-3) and MT6 (5-GAACACTTACTGTGAGGGTCTGGGCCA
TAG-3) to delete 4 bp at the 3 end of exon II (Figure 1A). Thedelayed onset of clinical signs and restricted cellular
presence of the desired mutations was confirmed by sequence anal-movement are not essentially coupled and have different
ysis, and the modified MscI fragment was subcloned into the originalunderlying mechanisms, but both are regulated by TNF.
sites of the mouse TNF/LT genomic clone. In this way, the nucleo-Second, that solTNF is the main driving force for proper
tides encoding amino acids 1–9 of the mature TNF protein were
localization and movement of leukocytes. deleted, and an A→G substitution was made to generate the K11→E11
Recent studies have illustrated how use of CFA in mutation. A neomycin resistance cassette flanked by loxP sites was
inserted into the SmaI site in intron III of the TNF gene. This targetinginflammation models may artificially alter clinical out-
construct was used in transfection of Bruce 4 C57BL/6 ES cellscome (Matthys et al., 2000). Substantially reducing the
(Lemckert et al., 1997). G418-resistant clones were isolated andamount of adjuvant and, ideally, dispensing with it com-
screened for homologous recombination by nested-set PCR analy-pletely may enable more accurate reproduction of un-
sis, using screening strategies similar to that described in the gener-
derlying disease processes. To this end, if the M. tuber- ation of TNF/ mice (Ko¨rner et al., 1997a). Positive clones were
culosis dose was reduced by 90%, major differences in confirmed by Southern blot (Ko¨rner et al., 1997a), in which the tar-
geted allele resulted in a 1675 bp fragment (WT allele: 9400 bp).clinical disease in both TNF/ and memTNF/ mice
Two homologous recombinant ES cell clones were expanded, trans-were revealed: TNF/ mice were highly resistant to EAE
fected with a cre-recombinase encoding plasmid pICCre (Gu et al.,induction, and clinical signs were delayed and dramati-
1993), and G418-sensitive clones were selected. Successful removalcally reduced in memTNF/ mice. These data indicate
of the neomycin resistance cassette was confirmed by Southern blot
that during an inflammatory reaction that is not provoked and PCR analysis. Southern blot analysis utilized the introduction of
by strong adjuvant doses, TNF generally but solTNF an EcoRI site in intron III of TNF and a PCR-generated probe of
TNF exon I (probe II in Figure 1B, expected WT fragment: 2726 bp,more specifically plays a dominant role in pathogenesis.
targeted allele fragment: 1958 bp). PCR analysis made use of theTNF additionally plays an important role in combating
fact that the residual loxP site plus remaining plasmid sequence inintracellular bacterial infections and has been implicated
the targeted allele yields a longer (1100 bp) product than the WTin antiviral immunity (Riminton and Sedgwick, 2000).
allele (1000 bp) using sense primer 5-GCGTCCAGCTGACTAAA
Ongoing studies will determine the relative role of CATCCTTC-3 and antisense primer 5-ACCACTAGTTGGTTGCTTT
memTNF versus solTNF in the protective immune re- GAGAT-3 (arrows in Figure 1B). Two G418-sensitive ES cell clones
were microinjected into BALB/c blastocysts (Lemckert et al., 1997).sponse to these pathogens.
Male chimeras were mated with C57BL/6 females, and black coat-In summary, these studies describe the in vivo role
colored (germline) offspring were screened for transmission of theof memTNF in lymphoid tissue development and inflam-
mutated TNF allele via the same PCR used for screening of cre-mation in a system that does not rely on transgenic
transfected ES cells. Heterozygous mice were intercrossed to obtain
expression. A significant role for memTNF in normal WT (/), memTNF heterozygous (/), and memTNF homozygous
lymphoid structural integrity and chemokine induction (/) mice (Figure 1C).
is illustrated. Most importantly, despite published evi-
dence implicating memTNF as a potent inducer of in- Production of TNF by Macrophages In Vitro
Peritoneal exudate cells (PECs) were obtained by injecting miceflammatory processes, these studies indicate that nor-
intraperitoneally (i.p.) with 1 ml 4% thioglycollate and harvestingmally regulated memTNF in the absence of solTNF
cells from the peritoneal cavity 3 days later. For FACS analysis, cellsexhibits suboptimal proinflammatory functions in vivo.
were cultured (37C, 5% CO2) in RPMI containing 10% FCS, 55 
MThe implications for use of therapeutic agents that block
2-mercapthoethanol, 1 mM sodium pyruvate, 292 
g/ml glutamine,
TNF secretion are obvious. 100
M nonessential amino acids, 100 U/ml penicillin, and 100
g/ml
streptomycin for 1 hr. Adherent cells (95% F4/80 macrophages)
were further cultured with 1
g/ml LPS (from E. coli, serotype 055:B5;Experimental Procedures
Sigma) for 3 hr. Supernatant was collected for measurement of
solTNF by ELISA (Endogen) or bio-assay (killing of actinomycinGeneration of MemTNF/ Mice
D-treated WEHI-164 cells). The macrophages were detached usingA 6572 bp DraI fragment containing the genes for TNF and LT was
HBSS/5 mM EDTA. For FACS analysis, cells were preincubated atcloned into pUC19 as described (Ko¨rner et al., 1997a). A 917 bp
4C for 5 min with anti-FcRIII antibody (PharMingen, San Jose, CA)MscI fragment containing exons II and III of the TNF gene that
and stained with FITC-conjugated F4/80 mAb specific for mouseencode the TACE cleavage site was subcloned in a modified pBlue-
macrophages (Caltag) and PE-conjugated rat anti-mouse TNF mAbscript plasmid containing a MscI site. Using PCR-based site-di-
(XT22; PharMingen) or appropriate isotype control antibodies. Allrected mutagenesis, a deletion of 23 bp at the 5 end of exon III
stainings were performed at 4C in the dark and in the presence ofand a point mutation (A→G) of the 27th bp of exon III (Figure 1A)
10 mM sodium azide.were introduced. In the first step, 10 ng pBluescript containing the
MscI fragment was used as template in two reactions. One contained
generic sense primer MT1 (5-ATCGAATTCTGGCCAGGGGAAGAG MemTNF Mediated Killing of WEHI-164 Cells
Thioglycollate-elicited macrophages were cultured and stimulatedGGGATAAG-3) and antisense mutation primer MT4 (5-GGC
TCGTCCTGGAGGGGAAGAGACAAAG-3). The other reaction con- with LPS as described above. After detaching, cells were fixed with
1% paraformaldehyde in PBS at room temperature for 20 min. Acti-tained sense mutation primer MT3 (5-CCCCTCCAGGACGAGCCTG
TAGCCCACG-3) and generic antisense primer MT2 (5-GCTCTA nomycin D-pretreated WEHI-164 cells were seeded onto 96-well
flat-bottom tissue culture plates, 5  105 cells/well. Fixed macro-GATGGCCAGGAGGGCGTTGGCGC-3). After an initial denaturation
step (94C, 5 min), 15 cycles were performed at 94C for 30 s, 58C phages were added in effector (macrophage)-to-target (WEHI-164)
ratios ranging from 1-to-1 to 1-to-100, and cells were incubated infor 30 s, and 72C for 1 min. Ten nanograms of each purified PCR
product was combined in the next reaction without addition of prim- the presence of actinomycin D and anti-mouse TNF (XT22, rat IgG1
isotype), rat IgG1 (as control for XT22; BD PharMingen), hamsterers for 5 cycles at 94C for 5 min, 58C for 3 min, and 72C for 1
min. The reaction mixture was kept at 94C, and primers MT1 and anti-mouse TNF-R1 (BD PharMingen; clone 55R-170), hamster anti-
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mouse TNF-R2 (BD PharMingen; clone TR75-54), or hamster Ig (as and his advice on procedures, Dr. Mike Tomlinson for transport of
samples between research sites, Dr. Maribel Andonian and Garycontrol for the anti-mouse TNFR antibodies; BD PharMingen). All
antibodies were purified, endotoxin- and azide-free, and used at a Burget for graphics, and the staff of the DNAX vivarium for ongoing
care of animals. DNAX is supported by Schering Plough Corporation,final concentration of 1 
g/100 
l. WEHI-164 cells were also incu-
bated with a standard curve (100 to 0.032 pg/ml) of soluble, recombi- New Jersey.
nant mouse TNF (Sigma). After overnight incubation, 50 
g MTT
(dissolved in PBS) was added, cells were cultured for 3 hr, plates Received May 31, 2001; revised August 17, 2001.
were spun at 700  g for 10 min, supernatants were removed, and
blue formazan crystals were dissolved in acidified isopropanol (100 References
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